England's NHS offers faster cancer drug injection

England's NHS is the first in Europe to offer a faster, subcutaneous injection of the cancer drug nivolumab, aiming to reduce clinic time and ease pressure on healthcare services. The new injectable version, approved by the MHRA, takes only 3-5 minutes to administer compared to the 30-60 minutes for the intravenous infusion, treating 15 cancer types. The change is expected to save around 1000 hours of treatment time monthly. The subcutaneous formulation, which will be available later this month, showed comparable efficacy to the IV version in trials and will benefit an estimated 1200 patients monthly, at no extra cost to the NHS.